Cambridge Investment Research Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25M	Buy	434,405 +30,063	+7%	+$1.73M	0.06%	337
2026 Q1	$24.5M	Buy	404,342 +14,156	+4%	+$825K	0.06%	314
2025 Q4	$21M	Buy	390,186 +63,605	+19%	+$3.06M	0.06%	352
2025 Q3	$14.7M	Sell	326,581 -59,731	-15%	-$2.79M	0.04%	444
2025 Q2	$17.9M	Sell	386,312 -75,830	-16%	-$3.72M	0.05%	349
2025 Q1	$28.2M	Sell	462,142 -51,585	-10%	-$3.01M	0.1%	215
2024 Q4	$29.1M	Buy	513,727 +137,203	+36%	+$7.67M	0.1%	196
2024 Q3	$19.5M	Buy	376,524 +17,086	+5%	+$802K	0.07%	287
2024 Q2	$14.9M	Sell	359,438 -60,504	-14%	-$2.71M	0.06%	344
2024 Q1	$22.8M	Sell	419,942 -12,419	-3%	-$633K	0.09%	220
2023 Q4	$22.2M	Sell	432,361 -37,023	-8%	-$1.94M	0.09%	204
2023 Q3	$27.2M	Sell	469,384 -61,803	-12%	-$3.79M	0.13%	157
2023 Q2	$34M	Sell	531,187 -52,634	-9%	-$3.53M	0.15%	128
2023 Q1	$40.5M	Buy	583,821 +99,775	+21%	+$7.04M	0.2%	101
2022 Q4	$34.8M	Buy	484,046 +15,637	+3%	+$1.18M	0.18%	106
2022 Q3	$33.3M	Sell	468,409 -6,026	-1%	-$437K	0.19%	97
2022 Q2	$36.5M	Buy	474,435 +11,565	+2%	+$881K	0.2%	97
2022 Q1	$33.8M	Sell	462,870 -8,914	-2%	-$599K	0.16%	125
2021 Q4	$29.4M	Buy	471,784 +19,601	+4%	+$1.15M	0.13%	163
2021 Q3	$26.8M	Sell	452,183 -707,141	-61%	-$46.6M	0.13%	164
2021 Q2	$77.5M	Sell	1,159,324 -59,973	-5%	-$3.91M	0.37%	47
2021 Q1	$77M	Sell	1,219,297 -132,487	-10%	-$8.24M	0.42%	41
2020 Q4	$83.9M	Sell	1,351,784 -32,354	-2%	-$1.99M	0.49%	27
2020 Q3	$83.5M	Buy	1,384,138 +941,541	+213%	+$56.7M	0.56%	22
2020 Q2	$26M	Buy	442,597 +25,973	+6%	+$1.55M	0.2%	103
2020 Q1	$23.2M	Buy	416,624 +11,874	+3%	+$726K	0.22%	93
2019 Q4	$26M	Buy	404,750 +157,161	+63%	+$9M	0.2%	109
2019 Q3	$12.6M	Buy	247,589 +9,021	+4%	+$424K	0.11%	185
2019 Q2	$10.8M	Buy	238,568 +18,865	+9%	+$879K	0.1%	206
2019 Q1	$10.5M	Buy	219,703 +12,339	+6%	+$615K	0.1%	197
2018 Q4	$10.8M	Sell	207,364 -23,466	-10%	-$1.26M	0.12%	173
2018 Q3	$14.3M	Buy	230,830 +13,850	+6%	+$822K	0.14%	155
2018 Q2	$12M	Sell	216,980 -2,387	-1%	-$129K	0.13%	162
2018 Q1	$13.9M	Buy	219,367 +9,839	+5%	+$633K	0.16%	132
2017 Q4	$12.8M	Buy	209,528 +21,391	+11%	+$1.34M	0.15%	140
2017 Q3	$12M	Buy	188,137 +12,737	+7%	+$744K	0.16%	125
2017 Q2	$9.77M	Buy	175,400 +7,404	+4%	+$403K	0.14%	134
2017 Q1	$9.14M	Sell	167,996 -11,945	-7%	-$655K	0.16%	127
2016 Q4	$10.5M	Buy	179,941 +7,314	+4%	+$400K	0.2%	103
2016 Q3	$9.31M	Buy	172,627 +16,737	+11%	+$1.08M	0.17%	109
2016 Q2	$11.5M	Buy	155,890 +5,737	+4%	+$405K	0.24%	87
2016 Q1	$9.59M	Sell	150,153 -327	-0.2%	-$20.6K	0.22%	92
2015 Q4	$10.4M	Buy	150,480 +9,500	+7%	+$628K	0.25%	88
2015 Q3	$8.35M	Sell	140,980 -10,615	-7%	-$673K	0.24%	86
2015 Q2	$10.1M	Sell	151,595 -511	-0.3%	-$33.7K	0.28%	78
2015 Q1	$9.81M	Sell	152,106 -546	-0.4%	-$34.2K	0.28%	79
2014 Q4	$9.01M	Buy	152,652 +6,063	+4%	+$342K	0.28%	78
2014 Q3	$7.5M	Buy	146,589 +8,308	+6%	+$415K	0.22%	98
2014 Q2	$6.71M	Buy	138,281 +7,398	+6%	+$365K	0.23%	96
2014 Q1	$6.8M	Buy	130,883 +755	+0.6%	+$40.2K	0.26%	84
2013 Q4	$6.92M	Buy	130,128 +704	+0.5%	+$35.9K	0.28%	70
2013 Q3	$5.99M	Buy	129,424 +5,181	+4%	+$227K	0.26%	83
2013 Q2	$5.55M	Buy	+124,243	New	+$5.39M	0.28%	77

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Cambridge Investment Research Advisors's BMY Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Bristol-Myers Squibb (BMY) stake by 7.4% in Q2 2026, buying an estimated $1.73M and bringing the position to 434,405 shares worth $25M. The position accounts for 0.06% of the portfolio, ranked #337.

Cambridge Investment Research Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $83.9M in Q4 2020. 954 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cambridge Investment Research Advisors held 434,405 shares of Bristol-Myers Squibb worth $25M as of Q2 2026.
Cambridge Investment Research Advisors bought 30,063 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.73M.
Bristol-Myers Squibb made up 0.06% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #337 holding.
Cambridge Investment Research Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Cambridge Investment Research Advisors's Bristol-Myers Squibb position peaked at $83.9M in Q4 2020.
954 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.